Capital Fund Management S.A. acquired a new stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 71,100 shares of the medical equipment provider’s stock, valued at approximately $8,085,000. Capital Fund Management S.A. owned approximately 0.08% of Varian Medical Systems as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of VAR. Wells Fargo & Company MN boosted its position in Varian Medical Systems by 1.3% in the first quarter. Wells Fargo & Company MN now owns 1,222,038 shares of the medical equipment provider’s stock valued at $149,882,000 after buying an additional 16,202 shares during the last quarter. SG Americas Securities LLC boosted its position in Varian Medical Systems by 7.5% in the first quarter. SG Americas Securities LLC now owns 22,201 shares of the medical equipment provider’s stock valued at $2,723,000 after buying an additional 1,555 shares during the last quarter. Mackay Shields LLC purchased a new stake in Varian Medical Systems in the first quarter valued at approximately $3,545,000. Massachusetts Financial Services Co. MA purchased a new stake in Varian Medical Systems in the first quarter valued at approximately $377,000. Finally, Schwab Charles Investment Management Inc. boosted its position in Varian Medical Systems by 77.1% in the first quarter. Schwab Charles Investment Management Inc. now owns 813,274 shares of the medical equipment provider’s stock valued at $99,749,000 after buying an additional 353,938 shares during the last quarter. Hedge funds and other institutional investors own 92.99% of the company’s stock.

Varian Medical Systems stock opened at $106.55 on Monday. Varian Medical Systems, Inc. has a 12 month low of $98.34 and a 12 month high of $130.29. The company has a market capitalization of $9.75 billion, a price-to-earnings ratio of 29.60, a P/E/G ratio of 2.99 and a beta of 0.79.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, July 25th. The medical equipment provider reported $1.04 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.99 by $0.05. Varian Medical Systems had a return on equity of 27.51% and a net margin of 4.07%. The business had revenue of $709.10 million for the quarter, compared to analyst estimates of $663.19 million. During the same quarter in the prior year, the firm posted $1.04 EPS. The business’s quarterly revenue was up 12.1% compared to the same quarter last year. sell-side analysts forecast that Varian Medical Systems, Inc. will post 4.46 earnings per share for the current year.

In other Varian Medical Systems news, SVP John W. Kuo sold 962 shares of the company’s stock in a transaction that occurred on Wednesday, August 15th. The stock was sold at an average price of $108.84, for a total value of $104,704.08. Following the sale, the senior vice president now owns 30,848 shares in the company, valued at approximately $3,357,496.32. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Timothy E. Guertin sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 5th. The stock was sold at an average price of $110.84, for a total value of $1,108,400.00. Following the completion of the sale, the director now owns 4,113 shares in the company, valued at approximately $455,884.92. The disclosure for this sale can be found here. In the last 90 days, insiders sold 16,418 shares of company stock worth $1,841,654. Insiders own 0.78% of the company’s stock.

VAR has been the topic of a number of recent research reports. JPMorgan Chase & Co. lowered Varian Medical Systems from a “neutral” rating to an “underweight” rating and set a $105.00 target price on the stock. in a research report on Thursday, June 28th. Zacks Investment Research upgraded Varian Medical Systems from a “sell” rating to a “hold” rating in a research report on Thursday, August 23rd. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $117.43.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

See Also: Understanding Price to Earnings Ratio (PE)

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.